Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Treatment Initiation Among Black and White Older Adults With Multiple Myeloma: A SEER‐Medicare Analysis

Title: Treatment Initiation Among Black and White Older Adults With Multiple Myeloma: A SEER‐Medicare Analysis
Authors: Matthew R. LeBlanc; Xi Zhou; Christopher D. Baggett; Jennifer L. Lund; Christopher E. Jensen; Tzy‐Mey Kuo; Bradford E. Jackson; Mya L. Roberson; Sascha A. Tuchman; Samuel M. Rubinstein; Eben I. Lichtman; Laura E. Green; Katherine E. Reeder‐Hayes
Source: Cancer Medicine, Vol 15, Iss 2, Pp n/a-n/a (2026)
Publisher Information: Wiley
Publication Year: 2026
Collection: Directory of Open Access Journals: DOAJ Articles
Subject Terms: health disparities; health services research; multiple myeloma; SEER‐Medicare; treatment initiation; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
Description: Background This study aims to describe time to treatment initiation for Black and White older adults with multiple myeloma (MM), and to test the hypothesis that Black/White disparities in treatment initiation have increased over time. Methods Black and White older adults (65+) diagnosed with myeloma 2007–2017 were identified in the SEER‐Medicare database. Continuous Medicare Parts A/B coverage 12 months before and after diagnosis or until death, and Part D coverage for 12 months following diagnosis or until death were required for inclusion. We explored time to treatment initiation by race across three diagnosis time periods (2007–10, 2011–2014, 2015–2017) using Cox proportional hazard models. We estimated cumulative incidence of treatment initiation by race at 3, 6, and 12 months after diagnosis for all time periods. Results White MM patients were more likely to initiate treatment than Black MM patients across time periods. Hazard ratios (HR) and 95% confidence intervals (CI) ranged from HR = 1.35 (95% CI: 1.25, 1.46) to HR = 1.36 (95% CI: 1.27, 1.44). Black/White differences in the cumulative incidence of treatment initiation at 3, 6, and 12 months were also significant and persistent across time periods, ranging from 0.09 (95% CI: 0.02, 0.15) to 0.11 (95% CI: 0.05, 0.17). Contrary to our hypothesis, Black/White disparities were not increasing over time. Conclusion Our results suggest that Black patients initiate MM treatment later than White patients and are less likely to ever initiate treatment. Contrary to our hypothesis, Black/White disparities are not increasing over time and have remained static.
Document Type: article in journal/newspaper
Language: English
Relation: https://doi.org/10.1002/cam4.71563; https://doaj.org/toc/2045-7634; https://doaj.org/article/18a5be88cf644117b041d739113377d7
DOI: 10.1002/cam4.71563
Availability: https://doi.org/10.1002/cam4.71563; https://doaj.org/article/18a5be88cf644117b041d739113377d7
Accession Number: edsbas.484C1D93
Database: BASE